...
首页> 外文期刊>Letters in drug design & discovery >Synthesis and Antitumor Activity of Novel N-Benzoyl-N '-substituted Pyrimidinyl (Thio)semicarbazide Derivatives
【24h】

Synthesis and Antitumor Activity of Novel N-Benzoyl-N '-substituted Pyrimidinyl (Thio)semicarbazide Derivatives

机译:新型N-苯甲酰基-N'-取代的嘧啶基(硫代)氨基脲衍生物的合成及抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

A series of substituted pyrimidinyl (thio) semicarbazide derivatives were designed and synthesized. The antitumor results showed that the activity of thiosemicarbazide compounds (series II) was generally higher than that of the corresponding semicarbazide derivatives (series I). Among them, IIk displayed higher cytotoxicity against HL-60, BGC-823 and Bel-7402 than that of adriamycin and exhibited broad in vitro cytotoxicity against 13 human tumor cell lines. Meanwhile, the cytotoxic selectivity and anti-multidrug resistance were evaluated, and IIk exhibited selective cytotoxicity against cancer cells in comparison to human normal cells and had significant anti-multidrug resistance capability. The bioassay results showed that IIk showed great promise as a potent lead compound for further antitumor discovery.
机译:设计并合成了一系列取代的嘧啶基(硫代)氨基脲衍生物。抗肿瘤结果表明,硫代氨基脲化合物(系列II)的活性通常高于相应的氨基脲衍生物(系列I)的活性。其中,IIk显示出对HL-60,BGC-823和Bel-7402的细胞毒性高于阿霉素,并且对13种人肿瘤细胞系具有广泛的体外细胞毒性。同时,评估了细胞毒性选择性和抗多药耐药性,并且IIk与人类正常细胞相比对癌细胞具有选择性的细胞毒性,并且具有显着的抗多药耐药性。生物测定结果表明,IIk作为有效的铅化合物具有广阔的前景,可用于进一步的抗肿瘤发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号